{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:03:31Z","timestamp":1789898611366,"version":"4.0.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":639,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/bjd.12607","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T07:31:12Z","timestamp":1378452672000},"page":"1304-1309","source":"Crossref","is-referenced-by-count":93,"title":["The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre"],"prefix":"10.1093","volume":"169","author":[{"given":"H.Y.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Dermatology; Singapore General Hospital; Outram Road Singapore 169608"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.L.","family":"Lim","sequence":"additional","affiliation":[{"name":"National Skin Centre; Department of Dermatology; Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Thirumoorthy","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Singapore General Hospital; Outram Road Singapore 169608"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Singapore General Hospital; Outram Road Singapore 169608"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"10.1111\/bjd.12607-BIB0001|bjd12607-cit-0001","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12607-BIB0002|bjd12607-cit-0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis: incidence and drug etiology in France, 1981-1985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0003|bjd12607-cit-0003","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/bjd.12607-BIB0004|bjd12607-cit-0004","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"A clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0005|bjd12607-cit-0005","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0006|bjd12607-cit-0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatment on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12607-BIB0007|bjd12607-cit-0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12607-BIB0008|bjd12607-cit-0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/BCR.0b013e31820aafbc","article-title":"Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study","volume":"32","author":"Sekula","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1111\/bjd.12607-BIB0009|bjd12607-cit-0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","article-title":"SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center","volume":"29","author":"Cartotto","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1111\/bjd.12607-BIB0010|bjd12607-cit-0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archderm.140.7.890","article-title":"Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States","volume":"140","author":"Trent","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0011|bjd12607-cit-0011","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1468-3083.2012.04502.x","article-title":"SCORTEN and impaired renal function related to mortality of toxic epidermal necrolysis patients in the Asian population","volume":"27","author":"Hu","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12607-BIB0012|bjd12607-cit-0012","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00015550510038232","article-title":"Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients","volume":"85","author":"Kim","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12607-BIB0013|bjd12607-cit-0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","article-title":"Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience","volume":"139","author":"Trent","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0014|bjd12607-cit-0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective non comparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0015|bjd12607-cit-0015","first-page":"430","article-title":"High dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis","volume":"83","author":"Campione","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12607-BIB0016|bjd12607-cit-0016","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-0214","article-title":"Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"87","author":"Kardaun","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12607-BIB0017|bjd12607-cit-0017","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","article-title":"Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"163","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12607-BIB0018|bjd12607-cit-0018","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/bjd.12607-BIB0019|bjd12607-cit-0019","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12607-BIB0020|bjd12607-cit-0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12607-BIB0021|bjd12607-cit-0021","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1111\/bjd.12607-BIB0022|bjd12607-cit-0022","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1365-2230.2001.00910.x","article-title":"Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam","volume":"26","author":"Meer","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12607-BIB0023|bjd12607-cit-0023","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Ar\u00e9valo","year":"2000","journal-title":"J Trauma"},{"key":"10.1111\/bjd.12607-BIB0024|bjd12607-cit-0024","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0190-9622(08)80969-3","article-title":"Efficacy of cyclophosphamide in toxic epidermal necrolysis, clinical and pathophysiologic aspects","volume":"25","author":"Heng","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12607-BIB0025|bjd12607-cit-0025","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.1985.01660120074023","article-title":"Plasmapheresis in severe drug-induced toxic epidermal necrolysis","volume":"121","author":"Kamanabroo","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0026|bjd12607-cit-0026","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-\u03b1 treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12607-BIB0027|bjd12607-cit-0027","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1684\/ejd.2008.0580","article-title":"Guidelines on the use of high-dose intravenous immunoglobulin in dermatology","volume":"19","author":"Enk","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.12607-BIB0028|bjd12607-cit-0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2310\/7750.2006.00048","article-title":"Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology","volume":"10","author":"Mydlarski","year":"2006","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/bjd.12607-BIB0029|bjd12607-cit-0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1440-0960.2009.00578.x","article-title":"The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: a review","volume":"51","author":"Smith","year":"2010","journal-title":"Australas J Dermatol"},{"key":"10.1111\/bjd.12607-BIB0030|bjd12607-cit-0030","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12607-BIB0031|bjd12607-cit-0031","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archdermatol.2011.300","article-title":"In a patient with toxic epidermal necrolysis, does intravenous immunoglobulin improve survival compared with supportive care?","volume":"147","author":"Wootton","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0032|bjd12607-cit-0032","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12607-BIB0033|bjd12607-cit-0033","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00130832-200308000-00006","article-title":"Intravenous immunoglobulins in the treatment of severe drug eruptions","volume":"3","author":"Bachot","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/bjd.12607-BIB0034|bjd12607-cit-0034","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archdermatol.2011.1610","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis","volume":"147","author":"Feldmeyer","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0035|bjd12607-cit-0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archderm.139.1.85","article-title":"Treatment of toxic epidermal necrolysis: the uncertainty persists but the fog is dispersing","volume":"139","author":"Wolff","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12607-BIB0036|bjd12607-cit-0036","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2133.2012.11032.x","article-title":"IVIg in TEN: time to re-evaluate the efficacy of intravenous immunoglobulin in the management of toxic epidermal necrolysis","volume":"167","author":"Walsh","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12607-BIB0037|bjd12607-cit-0037","first-page":"767","article-title":"Cutaneous adverse drug reactions in hospitalized patients","volume":"51","author":"Lee","year":"2010","journal-title":"Singapore Med J"},{"key":"10.1111\/bjd.12607-BIB0038|bjd12607-cit-0038","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2133.2012.11074.x","article-title":"The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies","volume":"167","author":"Lee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12607-BIB0039|bjd12607-cit-0039","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","article-title":"Toxic epidermal necrolysis","volume":"9","author":"Becker","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/bjd.12607-BIB0040|bjd12607-cit-0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12607","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12607\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T10:37:19Z","timestamp":1688467039000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/169\/6\/1304\/6615009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12607","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}